Advisory Committee To Revisit Boxed Warning For Protopic, Elidel
This article was originally published in The Pink Sheet Daily
Executive Summary
Six years after recommending boxed warnings and medication guides for Novartis' Elidel (pimecrolimus) and Astellas' Protopic (tacrolimus), the Pediatric Advisory Committee will hear updates on their safety.